Literature DB >> 12772192

Prostatic androgen repressed message-1 (PARM-1) may play a role in prostatic cell immortalisation.

Anne M Cornet1, Emmanuel Hanon, Eric R Reiter, Marc Bruyninx, Viet Ha Nguyen, Benoît R Hennuy, Georges P Hennen, Jean L Closset.   

Abstract

BACKGROUND: Prostatic androgen-repressed message-1 (PARM-1) has been cloned from the prostate. The transcript of the PARM-1 gene is overexpressed during regression of the prostate after androgen withdrawal. The regulation of PARM-1 by androgens is limited to this organ. We have studied the effects of PARM-1 overexpression in malignant prostate cells.
METHODS: The PARM-1 cDNA was introduced into the rat cancer cell line MAT LyLu along with a doxycycline-dependent regulator.
RESULTS: Maximal expression of PARM-1 (fivefold induction) was achieved by incubating the cells with 2 microM doxycycline for 48 hr. A study investigating the effect of PARM-1 overexpression on the transcription of 588 genes has shown that the TLP1 gene (encoding rat telomerase protein component 1) was the most up-regulated (fourfold). In addition, a dose-dependent increase in telomerase activity was observed in cells overexpressing PARM-1. In vivo, the androgen-deprived prostate showed an increased TLP1 level and increased telomerase activity.
CONCLUSIONS: Increased telomerase activity is often associated with the immortalisation of cancer cell lines, particularly prostatic ones. This could mean that PARM-1 is involved, via increased telomerase activity, in a survival program enabling certain prostatic cells to resist apoptosis, thus conferring a selective advantage to pre-cancerous or cancerous cells. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12772192     DOI: 10.1002/pros.10254

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  9 in total

1.  PARM-1 is an endoplasmic reticulum molecule involved in endoplasmic reticulum stress-induced apoptosis in rat cardiac myocytes.

Authors:  Koji Isodono; Tomosaburo Takahashi; Hiroko Imoto; Naohiko Nakanishi; Takehiro Ogata; Satoshi Asada; Atsuo Adachi; Tomomi Ueyama; Hidemasa Oh; Hiroaki Matsubara
Journal:  PLoS One       Date:  2010-03-18       Impact factor: 3.240

2.  Generation of mice deficient in both KLF3/BKLF and KLF8 reveals a genetic interaction and a role for these factors in embryonic globin gene silencing.

Authors:  Alister P W Funnell; Ka Sin Mak; Natalie A Twine; Gregory J Pelka; Laura J Norton; Tania Radziewic; Melinda Power; Marc R Wilkins; Kim S Bell-Anderson; Stuart T Fraser; Andrew C Perkins; Patrick P Tam; Richard C M Pearson; Merlin Crossley
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

3.  Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome.

Authors:  Jeroen Aerssens; Michael Camilleri; Willem Talloen; Leen Thielemans; Hinrich W H Göhlmann; Ilse Van Den Wyngaert; Theo Thielemans; Ronald De Hoogt; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Busciglio; Duane D Burton; Thomas Smyrk; Raul Urrutia; Bernard Coulie
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02       Impact factor: 11.382

4.  Prostate androgen-regulated mucin-like protein 1: a novel regulator of progesterone metabolism.

Authors:  Ji Yeon Park; Hyein Jang; Thomas E Curry; Aiko Sakamoto; Misung Jo
Journal:  Mol Endocrinol       Date:  2013-10-01

5.  Characterization and identification of PARM-1 as a new potential oncogene.

Authors:  Cyndia Charfi; Louis-Charles Levros; Elsy Edouard; Eric Rassart
Journal:  Mol Cancer       Date:  2013-07-31       Impact factor: 27.401

6.  Computational identification of surrogate genes for prostate cancer phases using machine learning and molecular network analysis.

Authors:  Rudong Li; Xiao Dong; Chengcheng Ma; Lei Liu
Journal:  Theor Biol Med Model       Date:  2014-08-23       Impact factor: 2.432

7.  Importance of prostate androgen-regulated mucin-like protein 1 in development of the bovine blastocyst.

Authors:  Adriana M Zolini; Verónica M Negrón-Pérez; Peter J Hansen
Journal:  BMC Dev Biol       Date:  2019-07-05       Impact factor: 1.978

8.  Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens.

Authors:  Devivasha Bordoloi; Peng Xiao; Hyeree Choi; Michelle Ho; Alfredo Perales-Puchalt; Makan Khoshnejad; J Joseph Kim; Laurent Humeau; Alagarsamy Srinivasan; David B Weiner; Kar Muthumani
Journal:  Genes Cancer       Date:  2021-03-22

9.  Family Wide Molecular Adaptations to Underground Life in African Mole-Rats Revealed by Phylogenomic Analysis.

Authors:  Kalina T J Davies; Nigel C Bennett; Georgia Tsagkogeorga; Stephen J Rossiter; Christopher G Faulkes
Journal:  Mol Biol Evol       Date:  2015-08-29       Impact factor: 16.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.